Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Clinical Pharmacology

Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial

Diabetes, Obesity and Metabolism | Sep 05, 2021 Clinical Pharmacology

Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis

JAMA Psychiatry | Sep 04, 2021 Clinical Pharmacology

Effects of fluoxetine on outcomes at 12 months after acute stroke: Results from EFFECTS, a randomized controlled trial

Stroke | Sep 04, 2021 Clinical Pharmacology

Effects of spironolactone and chlorthalidone on cardiovascular structure and function in chronic kidney disease

Clinical Journal of the American Society of Nephrology | Sep 03, 2021 Clinical Pharmacology

Clinical effects of early and short-term tolvaptan administration in patients hospitalized for acute decompensated heart failure

Cardiology | Sep 03, 2021 Clinical Pharmacology

Cardiovascular events with finerenone in kidney disease and type 2 diabetes

New England Journal of Medicine | Sep 02, 2021 Clinical Pharmacology

Empagliflozin in heart failure with a preserved ejection fraction

New England Journal of Medicine | Sep 02, 2021 Clinical Pharmacology

Edoxaban vs vitamin K antagonist for atrial fibrillation after TAVR

New England Journal of Medicine | Sep 02, 2021 Clinical Pharmacology

Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: A machine learning cluster analysis

The Lancet | Sep 02, 2021 Clinical Pharmacology

Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines vs standard dose monotherapy in patients with hypertension (QUARTET): A phase 3, randomized, double-blind, active-controlled trial

The Lancet | Sep 02, 2021 Clinical Pharmacology

« Prev 1 … 39 40 41 42 43 … 338 Next »

Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial

Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis

Effects of fluoxetine on outcomes at 12 months after acute stroke: Results from EFFECTS, a randomized controlled trial

Effects of spironolactone and chlorthalidone on cardiovascular structure and function in chronic kidney disease

Clinical effects of early and short-term tolvaptan administration in patients hospitalized for acute decompensated heart failure

Cardiovascular events with finerenone in kidney disease and type 2 diabetes

Empagliflozin in heart failure with a preserved ejection fraction

Edoxaban vs vitamin K antagonist for atrial fibrillation after TAVR

Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: A machine learning cluster analysis

Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines vs standard dose monotherapy in patients with hypertension (QUARTET): A phase 3, randomized, double-blind, active-controlled trial

Alternative Therapies and Infection Management

Managing Polypharmacy in Elderly Patients

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Recent Advances in Storage Media for Avulsed Tooth

Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial

Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis

Effects of fluoxetine on outcomes at 12 months after acute stroke: Results from EFFECTS, a randomized controlled trial

Effects of spironolactone and chlorthalidone on cardiovascular structure and function in chronic kidney disease

Clinical effects of early and short-term tolvaptan administration in patients hospitalized for acute decompensated heart failure

Cardiovascular events with finerenone in kidney disease and type 2 diabetes

Empagliflozin in heart failure with a preserved ejection fraction

Edoxaban vs vitamin K antagonist for atrial fibrillation after TAVR

Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: A machine learning cluster analysis

Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines vs standard dose monotherapy in patients with hypertension (QUARTET): A phase 3, randomized, double-blind, active-controlled trial

Alternative Therapies and Infection Management

Managing Polypharmacy in Elderly Patients

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Recent Advances in Storage Media for Avulsed Tooth

Select Specialty

Select Topic